Arkoprovo Paul

Arkoprovo Paul is a prominent researcher and entrepreneur with extensive experience in the fields of neuroscience and biotechnology. Currently serving as a Co-Founder at Oltera and a Postdoctoral Research Fellow at the University of Cambridge, Paul leads projects focusing on the phenotypes of human induced pluripotent stem cell-derived neurons, astrocytes, and microglia, utilizing advanced technologies like CRISPR/Cas9. Previously, as a Doctoral Researcher at King’s College London, Paul established a novel in-vitro cellular reprogramming model to study autism candidate genes and characterized cellular phenotypes in relation to neurodegenerative diseases. Education credentials include a PhD in Psychiatry/Clinical Neuroscience from the University of Cambridge, along with various fellowships and innovation roles that underscore a strong commitment to advancing life sciences through research and entrepreneurship.